CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award SVP, Chief Accounting Officer acquired 79,000 shares (grant or award)
- 4 Grant or award SVP, CFO, CBO & Treasurer acquired 204,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 743,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, CFO, CBO & Treasurer sold 41,314 shares at $3.67 ($151,622)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Grant or award Director acquired 35,700 shares (grant or award)
- 4 Planned sale SVP, Chief Accounting Officer sold 15,000 shares at $4.01 ($60,150)
- 4 Planned sale SVP, Chief Accounting Officer sold 13,334 shares at $3.53 ($47,069)
- 4 Planned sale CEO and President sold 46,409 shares at $1.83 ($84,928)
- 4 Planned sale SVP, Chief Medical Officer sold 7,144 shares at $1.83 ($13,074)
- 4 Planned sale CEO and President sold 144,250 shares at $2.10 ($302,925)
- 4 Planned sale SVP, Chief Medical Officer sold 50,506 shares at $2.10 ($106,063)
- 4 Planned sale SVP, Chief Accounting Officer sold 30,202 shares at $2.10 ($63,424)
- 4 Planned sale Chief Commercial Officer sold 55,621 shares at $2.10 ($116,804)
Page 2 of 19 · 378 filings